These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16014697)

  • 1. Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?
    Tessier MC; Qu HQ; Fréchette R; Bacot F; Grabs R; Taback SP; Lawson ML; Kirsch SE; Hudson TJ; Polychronakos C
    J Med Genet; 2006 Feb; 43(2):129-32. PubMed ID: 16014697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reassessment of the type I diabetes association of the OAS1 locus.
    Qu HQ; Polychronakos C;
    Genes Immun; 2009 Dec; 10 Suppl 1(Suppl 1):S69-73. PubMed ID: 19956105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the oligoadenylate synthetase gene cluster and its association with clinical outcomes of dengue virus infection.
    Alagarasu K; Honap T; Damle IM; Mulay AP; Shah PS; Cecilia D
    Infect Genet Evol; 2013 Mar; 14():390-5. PubMed ID: 23337612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis.
    Cagliani R; Fumagalli M; Guerini FR; Riva S; Galimberti D; Comi GP; Agliardi C; Scarpini E; Pozzoli U; Forni D; Caputo D; Asselta R; Biasin M; Paraboschi EM; Bresolin N; Clerici M; Sironi M
    Hum Genet; 2012 Jan; 131(1):87-97. PubMed ID: 21735172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OAS1 gene haplotype confers susceptibility to multiple sclerosis.
    Fedetz M; Matesanz F; Caro-Maldonado A; Fernandez O; Tamayo JA; Guerrero M; Delgado C; López-Guerrero JA; Alcina A
    Tissue Antigens; 2006 Nov; 68(5):446-9. PubMed ID: 17092260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluate the relationship between polymorphisms of OAS1 gene and susceptibility to chronic hepatitis C with high resolution melting analysis.
    Zhao Y; Kang H; Ji Y; Chen X
    Clin Exp Med; 2013 Aug; 13(3):171-6. PubMed ID: 22710942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans: implications for a North African Neanderthal connection.
    Yousfi FZE; Haroun AE; Nebhani C; Belayachi J; Askander O; Fahime EE; Fares H; Ennibi K; Abouqal R; Razine R; Bouhouche A
    Arch Virol; 2024 Apr; 169(5):109. PubMed ID: 38658463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in the 2'-5'-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease.
    Barkhash AV; Perelygin AA; Babenko VN; Myasnikova NG; Pilipenko PI; Romaschenko AG; Voevoda MI; Brinton MA
    J Infect Dis; 2010 Dec; 202(12):1813-8. PubMed ID: 21050126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polymorphism in the human 2'-5'-oligoadenylate synthetase genes (OAS), associated with predisposition to severe forms of tick-borne encephalitis, in populations from North Eurasia].
    Barkhash AV; Babenko VN; Kobzev VF; Romashchenko AG; Voevoda MI
    Mol Biol (Mosk); 2010; 44(6):985-93. PubMed ID: 21290821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism.
    Kjær KH; Pahus J; Hansen MF; Poulsen JB; Christensen EI; Justesen J; Martensen PM
    BMC Cell Biol; 2014 Sep; 15():33. PubMed ID: 25205466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Oligoadenylate Synthetase Gene Cluster and DC-SIGN (CD209) Gene Polymorphisms with Clinical Symptoms in Chikungunya Virus Infection.
    Chaaithanya IK; Muruganandam N; Surya P; Anwesh M; Alagarasu K; Vijayachari P
    DNA Cell Biol; 2016 Jan; 35(1):44-50. PubMed ID: 26398832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19.
    Huffman JE; Butler-Laporte G; Khan A; Pairo-Castineira E; Drivas TG; Peloso GM; Nakanishi T; ; Ganna A; Verma A; Baillie JK; Kiryluk K; Richards JB; Zeberg H
    Nat Genet; 2022 Feb; 54(2):125-127. PubMed ID: 35027740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine.
    Haralambieva IH; Dhiman N; Ovsyannikova IG; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    Hum Immunol; 2010 Apr; 71(4):383-91. PubMed ID: 20079393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association analysis of polymorphisms in OAS1 with susceptibility and severity of hand, foot and mouth disease.
    Cai Y; Chen Q; Zhou W; Chu C; Ji W; Ding Y; Xu J; Ji Z; You H; Wang J
    Int J Immunogenet; 2014 Oct; 41(5):384-92. PubMed ID: 25059424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection.
    Lin RJ; Yu HP; Chang BL; Tang WC; Liao CL; Lin YL
    J Immunol; 2009 Dec; 183(12):8035-43. PubMed ID: 19923450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man.
    Lim JK; Lisco A; McDermott DH; Huynh L; Ward JM; Johnson B; Johnson H; Pape J; Foster GA; Krysztof D; Follmann D; Stramer SL; Margolis LB; Murphy PM
    PLoS Pathog; 2009 Feb; 5(2):e1000321. PubMed ID: 19247438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of OAS1 Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 Patients.
    Bader El Din NG; Anany MA; Dawood RM; Ibrahim MK; El-Shenawy R; El Abd YS; El Awady MK
    Viral Immunol; 2015 Nov; 28(9):509-16. PubMed ID: 26505957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence for association of OAS1 with type 1 diabetes in unaffected siblings or type 1 diabetic cases.
    Smyth DJ; Cooper JD; Lowe CE; Nutland S; Walker NM; Clayton DG; Todd JA
    Diabetes; 2006 May; 55(5):1525-8. PubMed ID: 16644715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic structure of the mouse 2',5'-oligoadenylate synthetase gene family.
    Kakuta S; Shibata S; Iwakura Y
    J Interferon Cytokine Res; 2002 Sep; 22(9):981-93. PubMed ID: 12396720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes.
    Field LL; Bonnevie-Nielsen V; Pociot F; Lu S; Nielsen TB; Beck-Nielsen H
    Diabetes; 2005 May; 54(5):1588-91. PubMed ID: 15855350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.